ARCA Biopharma Inc ABIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12/03/21 EST
2.25UNCH (UNCH)
Volume
606,143
52 week range
2.17 - 5.50
Loading...
  • Open2.28
  • Day High2.33
  • Day Low2.18
  • Prev Close2.25
  • 52 Week High5.50
  • 52 Week High Date02/11/21
  • 52 Week Low2.17
  • 52 Week Low Date11/23/21

Key Stats

  • Market Cap32.42M
  • Shares Out14.41M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta2.59
  • YTD % Change-43.89

KEY STATS

  • Open2.28
  • Day High2.33
  • Day Low2.18
  • Prev Close2.25
  • 52 Week High5.50
  • 52 Week High Date02/11/21
  • 52 Week Low2.17
  • 52 Week Low Date11/23/21
  • Market Cap32.42M
  • Shares Out14.41M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta2.59
  • YTD % Change-43.89

RATIOS/PROFITABILITY

  • EPS (TTM)-1.54
  • P/E (TTM)-1.46
  • Fwd P/E (NTM)-0.25
  • EBITDA (TTM)-16.045M
  • ROE (TTM)-44.89%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ARCA Biopharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is focused on development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product includes Recombinant Nematode Anticoagulant Protein c2, or rNAPc2 (AB201) and Gencaro(bucindolol hydrochloride). rNAPc2 (AB201) is a treatment for diseases caused by ribonucleic acid (RNA), viruses, focusing on COVID-19, the disease syndrome caused by the SARS-CoV-2 virus....
Robert Conway CPA
Non-Executive Chairman
Michael Bristow M.D., Ph.D.
Chief Executive Officer
Thomas Keuer
Chief Operating Officer
C. Jeffrey Dekker CPA
Chief Financial Officer
Christopher Graybill Ph.D.
Vice President
Address
10170 Church Ranch Way, Suite 100
Westminster, CO
80021
United States

Top Peers

SYMBOLLASTCHG%CHG
MTCR
Metacrine, Inc.
1.26-0.03-2.33%
IDRA
Idera Pharmaceuticals Inc
0.60-0.051-7.8341%
CYCC
Cyclacel Pharmaceuticals Inc
3.24-0.24-6.90%
TENX
Tenax Therapeutics Inc
1.17-0.01-0.85%
CNSP
CNS Pharmaceuticals Inc
0.995-0.075-7.0093%
GRTX
Galera Therapeutics Inc
1.27UNCHUNCH